The efficacy of controlled release D-sotalol-polyurethane epicardial implants for ventricular arrhythmias due to acute ischemia in dogs
- 1 January 1993
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 23 (1) , 75-85
- https://doi.org/10.1016/0168-3659(93)90072-d
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Class III antiarrhythmic action of d-sotalol during hypothermiaAmerican Heart Journal, 1991
- Efficacy of Epicardial Controlled-Release Lidocaine for Ventricular Tachycardia Induced by Rapid Ventricular Pacing in DogsJournal of Cardiovascular Pharmacology, 1990
- A mechanism of D‐(+)‐sotalol effects on heart rate not related to beta‐ adrenoceptor antagonism.British Journal of Clinical Pharmacology, 1990
- Comparability of the Electrophysiologic Responses and Plasma and Myocardial Tissue Concentrations of Sotalol and its d Stereoisomer in the DogJournal of Cardiovascular Pharmacology, 1990
- Attenuation of the rise in extracellular potassium concentration during myocardial ischaemia by d.l-sotalol and d-sotalolCardiovascular Research, 1990
- Conversion of Ouabain-Induced Ventricular Tachycardia in Dogs with Epicardial Lidocaine: Pharmacodynamics and Functional EffectsPharmaceutical Research, 1990
- Sensitive high-performance liquid chromatographic assay using 9-fluorenylmethylchloroformate for monitoring controlled-release lidocaine in plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- Cardiac controlled release for arrhythmia therapy: Lidocaine-polyurethane matrix studiesJournal of Controlled Release, 1988
- Quantitative Liquid Chromatographic Determination of Sotalol in Human PlasmaTherapeutic Drug Monitoring, 1986
- Initial myocardial adjustments to brief periods of ischemia and reperfusion in the conscious dog.Circulation Research, 1978